X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1278) 1278
Book Review (394) 394
Publication (71) 71
Conference Proceeding (5) 5
Newsletter (5) 5
Book Chapter (3) 3
Magazine Article (2) 2
Data Set (1) 1
Dissertation (1) 1
Reference (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (1011) 1011
exenatide (859) 859
humans (742) 742
glucagon-like peptide-1 (573) 573
diabetes mellitus, type 2 - drug therapy (517) 517
type 2 diabetes (512) 512
animals (483) 483
glycemic control (455) 455
male (426) 426
endocrinology & metabolism (419) 419
diabetes (406) 406
hypoglycemic agents - therapeutic use (378) 378
exenatide exendin-4 (335) 335
glucose (312) 312
exendin-4 (308) 308
pharmacology & pharmacy (305) 305
peptides - pharmacology (284) 284
insulin (277) 277
liraglutide (263) 263
peptides - therapeutic use (259) 259
venoms - pharmacology (257) 257
female (251) 251
venoms - therapeutic use (237) 237
treated patients (226) 226
glp-1 (223) 223
peptides (220) 220
glucagon (214) 214
hypoglycemic agents - pharmacology (207) 207
metformin (199) 199
hypoglycemic agents - administration & dosage (198) 198
glucagon-like peptide-1 receptor (194) 194
rats (194) 194
mice (186) 186
middle aged (182) 182
peptides - administration & dosage (182) 182
hypoglycemic agents (176) 176
insulin - metabolism (169) 169
venoms - administration & dosage (167) 167
blood glucose - metabolism (164) 164
research (163) 163
glucagon-like peptide 1 - analogs & derivatives (156) 156
internal medicine (156) 156
drug therapy (150) 150
double-blind (149) 149
blood glucose - drug effects (146) 146
beta-cell function (143) 143
hypoglycemic agents - adverse effects (141) 141
care and treatment (138) 138
medicine, general & internal (137) 137
receptors, glucagon - agonists (136) 136
insulin secretion (135) 135
diabetes mellitus (133) 133
glucagon-like peptide 1 - therapeutic use (133) 133
sulfonylurea (132) 132
analysis (131) 131
glucagon-like peptide 1 (130) 130
open-label (130) 130
adult (129) 129
diabetes mellitus, type 2 - blood (129) 129
diabetes therapy (127) 127
obesity (124) 124
treatment outcome (123) 123
type-2 diabetes-mellitus (123) 123
metformin-treated patients (121) 121
dextrose (119) 119
aged (116) 116
diabetes mellitus, type 2 - metabolism (114) 114
health aspects (112) 112
peptides - adverse effects (109) 109
medicine & public health (105) 105
insulin resistance (104) 104
insulin-secretion (104) 104
abridged index medicus (103) 103
physiological aspects (100) 100
type 2 diabetes mellitus (100) 100
venoms - adverse effects (99) 99
sitagliptin (97) 97
medicine, research & experimental (96) 96
risk factors (95) 95
dipeptidyl peptidase-4 inhibitor (90) 90
insulin glargine (89) 89
rodents (89) 89
dosage and administration (88) 88
pharmacokinetics (85) 85
safety (83) 83
hyperglycemia (81) 81
receptor (81) 81
glycated hemoglobin a - metabolism (80) 80
incretins - therapeutic use (80) 80
weight (78) 78
glucagon-like peptide 1 - metabolism (77) 77
diabetes mellitus, type 2 - physiopathology (76) 76
drug therapy, combination (76) 76
hypoglycemic agents - pharmacokinetics (76) 76
body weight - drug effects (75) 75
mice, inbred c57bl (75) 75
peptides - pharmacokinetics (75) 75
rats, sprague-dawley (75) 75
synthetic exendin-4 (75) 75
improves glycemic control (74) 74
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1256) 1256
Spanish (10) 10
German (7) 7
French (4) 4
Chinese (3) 3
Korean (3) 3
Japanese (1) 1
Polish (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal Article
Brain, ISSN 0006-8950, 05/2017, Volume 140, Issue 5, pp. 1420 - 1436
Journal Article
Physiology & Behavior, ISSN 0031-9384, 2012, Volume 106, Issue 4, pp. 574 - 578
Journal Article
Journal Article
Diabetes, ISSN 0012-1797, 04/2010, Volume 59, Issue 4, pp. 1030 - 1037
Journal Article
Journal of Biological Chemistry, ISSN 0021-9258, 01/2006, Volume 281, Issue 2, pp. 1159 - 1168
Journal Article
PLoS ONE, ISSN 1932-6203, 12/2013, Volume 8, Issue 12, pp. e82016 - e82016
Traumatic brain injury represents a major public health issue that affects 1.7 million Americans each year and is a primary contributing factor (30.5%) of all... 
UNITED-STATES | GLUCAGON-LIKE PEPTIDE-1 | CONTROLLED CORTICAL IMPACT | SIGNALING PATHWAY | ALZHEIMERS-DISEASE | AMYLOID-BETA | MULTIDISCIPLINARY SCIENCES | MORRIS WATER MAZE | GENE-EXPRESSION | BINDING-SITES | TYPE-2 DIABETES-MELLITUS | Neuroprotective Agents - therapeutic use | Neurons - pathology | Brain Injuries - drug therapy | Humans | Male | Neurons - cytology | Brain Injuries - physiopathology | Hypoglycemic Agents | Neuroprotective Agents - pharmacology | Cell Death - drug effects | Neurons - drug effects | Rats | Receptors, Glucagon - metabolism | Drug Repositioning | Cognition - drug effects | Rats, Sprague-Dawley | Brain Injuries - prevention & control | Peptides - pharmacology | Animals | Glucagon-Like Peptide-1 Receptor | Signal Transduction - drug effects | Venoms - therapeutic use | Cell Line, Tumor | Venoms - pharmacology | Peptides - therapeutic use | Brain | Complications and side effects | Cognition disorders | Research | Drug therapy | Exenatide | Health aspects | Risk factors | Injuries | Epidemics | Neuroprotection | Animal models | Traumatic brain injury | Glucagon | Toxicity | Cognitive ability | Glucose | Kinases | Head injuries | Neurodegeneration | Rodents | Biocompatibility | Pancreas | Glucagon-like peptide 1 | Public health | Secretion | Therapeutic applications | Diabetes mellitus | Markers | Percussion | Insulin | Cell death | Apoptosis | Index Medicus
Journal Article
Journal Article
American Journal of Physiology - Renal Physiology, ISSN 0363-6127, 10/2012, Volume 303, Issue 7, pp. F963 - F971
Journal Article